More articles from Supplement

You have access
The Future of Nuclear Medicine as an Independent Specialty
Johannes Czernin, Ida Sonni, Aria Razmaria and Jeremie Calais

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 3S-12S; DOI: https://doi.org/10.2967/jnumed.118.220558
You have access
Nuclear Medicine and Wall Street: An Evolving Relationship
Mike Sherman and Rachel Levine

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 20S-24S; DOI: https://doi.org/10.2967/jnumed.118.220798
You have access
Radiomics: Data Are Also Images
Mathieu Hatt, Catherine Cheze Le Rest, Florent Tixier, Bogdan Badic, Ulrike Schick and Dimitris Visvikis

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 38S-44S; DOI: https://doi.org/10.2967/jnumed.118.220582
You have access
Driving the Future of Nuclear Medicine
Ken Herrmann, Patrick Veit-Haibach and Wolfgang A. Weber

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.119.232264
You have access
Do You Want an Inspirational Career? Choose Nuclear Medicine
Steven M. Larson

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 25S-28S; DOI: https://doi.org/10.2967/jnumed.118.220574
You have access
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein, Wolfgang A. Weber and Matthias Eiber

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.118.220566
You have access
Artificial Intelligence in Nuclear Medicine
Felix Nensa, Aydin Demircioglu and Christoph Rischpler

Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 29S-37S; DOI: https://doi.org/10.2967/jnumed.118.220590
You have access
Somatostatin Receptor 2–Targeting Compounds
Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
You have access
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani, Guillaume P. Nicolas and Damian Wild

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783
You have access
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

Main menu

User menu

Search

More articles from Supplement

Pages